{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:19:06Z","timestamp":1794331146840,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7904","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,4,7]]},"DOI":"10.1038\/s41586-022-04467-w","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T12:06:01Z","timestamp":1643889961000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":336,"title":["Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3"],"prefix":"10.1038","volume":"604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-2624","authenticated-orcid":false,"given":"Inga V.","family":"Hochheiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-4735","authenticated-orcid":false,"given":"Michael","family":"Pilsl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Hagelueken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-1359","authenticated-orcid":false,"given":"Jonas","family":"Moecking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Marleaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brinkschulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-5666","authenticated-orcid":false,"given":"Eicke","family":"Latz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-3599","authenticated-orcid":false,"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-5002","authenticated-orcid":false,"given":"Matthias","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"4467_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"4467_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"4467_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397\u2013411 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"4467_CR4","doi-asserted-by":"publisher","first-page":"16567","DOI":"10.1074\/jbc.M211596200","volume":"278","author":"RE Laliberte","year":"2003","unstructured":"Laliberte, R. E. et al. Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1\u03b2 posttranslational processing. J. Biol. Chem. 278, 16567\u201316578 (2003).","journal-title":"J. Biol. Chem."},{"key":"4467_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","volume":"68","author":"N Song","year":"2017","unstructured":"Song, N. et al. NLRP3 phosphorylation is an essential priming event for inflammasome activation. Mol. Cell 68, 185\u2013197 (2017).","journal-title":"Mol. Cell"},{"key":"4467_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1074\/jbc.C115.700492","volume":"291","author":"JL Schmid-Burgk","year":"2016","unstructured":"Schmid-Burgk, J. L. et al. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem. 291, 103\u2013109 (2016).","journal-title":"J. Biol. Chem."},{"key":"4467_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250\u2013258 (2016).","journal-title":"Nat. Immunol."},{"key":"4467_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He, Y., Zeng, M. Y., Yang, D., Motro, B. & N\u00fa\u00f1ez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354\u2013357 (2016).","journal-title":"Nature"},{"key":"4467_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588\u2013606 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"4467_CR10","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","volume":"197","author":"MJ Primiano","year":"2016","unstructured":"Primiano, M. J. et al. Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation. J. Immunol. 197, 2421\u20132433 (2016).","journal-title":"J. Immunol."},{"key":"4467_CR11","doi-asserted-by":"publisher","first-page":"127560","DOI":"10.1016\/j.bmcl.2020.127560","volume":"30","author":"D Harrison","year":"2020","unstructured":"Harrison, D. et al. Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors. Bioorg. Med. Chem. Lett. 30, 127560 (2020).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"4467_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255 (2015).","journal-title":"Nat. Med."},{"key":"4467_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000354","volume":"17","author":"L Vande Walle","year":"2019","unstructured":"Vande Walle, L. et al. MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. PLoS Biol. 17, e3000354 (2019).","journal-title":"PLoS Biol."},{"key":"4467_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","volume":"73","author":"SE Corcoran","year":"2021","unstructured":"Corcoran, S. E., Halai, R. & Cooper, M. A. Pharmacological inhibition of the Nod-like receptor family pyrin domain containing 3 inflammasome with MCC950. Pharmacol. Rev. 73, 968\u20131000 (2021).","journal-title":"Pharmacol. Rev."},{"key":"4467_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","volume":"570","author":"H Sharif","year":"2019","unstructured":"Sharif, H. et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature 570, 338\u2013343 (2019).","journal-title":"Nature"},{"key":"4467_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1006\/jmbi.1996.0694","volume":"264","author":"B Kobe","year":"1996","unstructured":"Kobe, B. & Deisenhofer, J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J. Mol. Biol. 264, 1028\u20131043 (1996).","journal-title":"J. Mol. Biol."},{"key":"4467_CR17","doi-asserted-by":"publisher","first-page":"39528","DOI":"10.1074\/jbc.M111.278812","volume":"286","author":"JY Bae","year":"2011","unstructured":"Bae, J. Y. & Park, H. H. Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly. J. Biol. Chem. 286, 39528\u201339536 (2011).","journal-title":"J. Biol. Chem."},{"key":"4467_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11813","volume":"7","author":"S Maekawa","year":"2016","unstructured":"Maekawa, S., Ohto, U., Shibata, T., Miyake, K. & Shimizu, T. Crystal structure of NOD2 and its implications in human disease. Nat. Commun. 7, 11813 (2016).","journal-title":"Nat. Commun."},{"key":"4467_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1126\/science.1236381","volume":"341","author":"Z Hu","year":"2013","unstructured":"Hu, Z. et al. Crystal structure of NLRC4 reveals its autoinhibition mechanism. Science 341, 172\u2013175 (2013).","journal-title":"Science"},{"key":"4467_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1126\/science.aao1140","volume":"358","author":"JL Tenthorey","year":"2017","unstructured":"Tenthorey, J. L. et al. The structural basis of flagellin detection by NAIP5: a strategy to limit pathogen immune evasion. Science 358, 888\u2013893 (2017).","journal-title":"Science"},{"key":"4467_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.biophys.35.040405.101933","volume":"35","author":"JP Erzberger","year":"2006","unstructured":"Erzberger, J. P. & Berger, J. M. Evolutionary relationships and structural mechanisms of AAA+ proteins. Annu. Rev. Biophys. Biomol. Struct. 35, 93\u2013114 (2006).","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"4467_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11076-1","volume":"10","author":"F Hoss","year":"2019","unstructured":"Hoss, F. et al. Alternative splicing regulates stochastic NLRP3 activity. Nat. Commun. 10, 3238 (2019).","journal-title":"Nat. Commun."},{"key":"4467_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/humu.20080","volume":"24","author":"I Touitou","year":"2004","unstructured":"Touitou, I. et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum. Mutat. 24, 194\u2013198 (2004).","journal-title":"Hum. Mutat."},{"key":"4467_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll, R. C. et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat. Chem. Biol. 15, 556\u2013559 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"4467_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","volume":"15","author":"A Tapia-Abell\u00e1n","year":"2019","unstructured":"Tapia-Abell\u00e1n, A. et al. MCC950 closes the active conformation of NLRP3 to an inactive state. Nat. Chem. Biol. 15, 560\u2013564 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"4467_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbamcr.2011.06.014","volume":"1823","author":"P Wendler","year":"2012","unstructured":"Wendler, P., Ciniawsky, S., Kock, M. & Kube, S. Structure and function of the AAA+ nucleotide binding pocket. Biochim. Biophys. Acta 1823, 2\u201314 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"4467_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.immuni.2012.06.013","volume":"37","author":"V Compan","year":"2012","unstructured":"Compan, V. et al. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37, 487\u2013500 (2012).","journal-title":"Immunity"},{"key":"4467_CR28","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1084\/jem.20162040","volume":"214","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J. Exp. Med. 214, 2671\u20132693 (2017).","journal-title":"J. Exp. Med."},{"key":"4467_CR29","doi-asserted-by":"publisher","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","volume":"115","author":"JP Green","year":"2018","unstructured":"Green, J. P. et al. Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc. Natl Acad. Sci. USA 115, E9371\u2013E9380 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4467_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07573-4","volume":"9","author":"I Hafner-Bratkovi\u010d","year":"2018","unstructured":"Hafner-Bratkovi\u010d, I. et al. NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway. Nat. Commun. 9, 5182 (2018).","journal-title":"Nat. Commun."},{"key":"4467_CR31","doi-asserted-by":"publisher","unstructured":"Hochheiser, I. V. et al. Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation. Preprint at https:\/\/doi.org\/10.1101\/2021.11.25.470035 (2021).","DOI":"10.1101\/2021.11.25.470035"},{"key":"4467_CR32","doi-asserted-by":"publisher","unstructured":"Andreeva, L. et al. Full-length NLRP3 forms oligomeric cages to mediate NLRP3 sensing and activation. Preprint at https:\/\/doi.org\/10.1101\/2021.09.12.459968 (2021).","DOI":"10.1101\/2021.09.12.459968"},{"key":"4467_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","volume":"64","author":"AG Schwaid","year":"2021","unstructured":"Schwaid, A. G. & Spencer, K. B. Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space. J. Med. Chem. 64, 101\u2013122 (2021).","journal-title":"J. Med. Chem."},{"key":"4467_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"4467_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"4467_CR36","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"4467_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"4467_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/pro.3791","volume":"29","author":"A Casa\u00f1al","year":"2020","unstructured":"Casa\u00f1al, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 29, 1055\u20131064 (2020).","journal-title":"Protein Sci."},{"key":"4467_CR39","doi-asserted-by":"publisher","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","volume":"433","author":"C Dekker","year":"2021","unstructured":"Dekker, C. et al. Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition. J. Mol. Biol. 433, 167309 (2021).","journal-title":"J. Mol. Biol."},{"key":"4467_CR40","doi-asserted-by":"publisher","unstructured":"Hochheiser, I. V. et al. Cryo-EM structure of the NLRP3 decamer bound to the cytokine release inhibitory drug CRID3. Preprint at https:\/\/doi.org\/10.1101\/2021.07.22.453353 (2021).","DOI":"10.1101\/2021.07.22.453353"},{"key":"4467_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"4467_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"4467_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/pro.3786","volume":"29","author":"MG Prisant","year":"2020","unstructured":"Prisant, M. G., Williams, C. J., Chen, V. B., Richardson, J. S. & Richardson, D. C. New tools in MolProbity validation: CaBLAM for cryoEM backbone, UnDowser to rethink \u201cwaters,\u201d and NGL Viewer to recapture online 3D graphics. Protein Sci. 29, 315\u2013329 (2020).","journal-title":"Protein Sci."},{"key":"4467_CR44","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"4467_CR45","doi-asserted-by":"publisher","first-page":"642273","DOI":"10.3389\/fchem.2021.642273","volume":"9","author":"T Keuler","year":"2021","unstructured":"Keuler, T. et al. Development of fluorescent and biotin probes targeting NLRP3. Front. Chem. 9, 642273 (2021).","journal-title":"Front. Chem."},{"key":"4467_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-62703-523-1_13","volume":"1040","author":"EM Kofoed","year":"2013","unstructured":"Kofoed, E. M. & Vance, R. E. Blue native polyacrylamide gel electrophoresis to monitor inflammasome assembly and composition. Methods Mol. Biol. 1040, 169\u2013183 (2013).","journal-title":"Methods Mol. Biol."},{"key":"4467_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4049\/jimmunol.1401110","volume":"194","author":"DP Sester","year":"2015","unstructured":"Sester, D. P. et al. A novel flow cytometric method to assess inflammasome formation. J. Immunol. 194, 455\u2013462 (2015).","journal-title":"J. Immunol."},{"key":"4467_CR48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.aac5789","volume":"350","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science 350, 404\u2013409 (2015).","journal-title":"Science"},{"key":"4467_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nsmb.2938","volume":"22","author":"K Park","year":"2015","unstructured":"Park, K. et al. Control of repeat-protein curvature by computational protein design. Nat. Struct. Mol. Biol. 22, 167\u2013174 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"4467_CR50","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04467-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T09:14:40Z","timestamp":1667812480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04467-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":50,"journal-issue":{"issue":"7904","published-print":{"date-parts":[[2022,4,7]]}},"alternative-id":["4467"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-04467-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.22.453353","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.G. and E.L. are co-founders and consultants of IFM Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}